Читать книгу The Dentist's Drug and Prescription Guide - Mea A. Weinberg - Страница 10

1 Aki, T., Heikkinen, A.T., Korjamo, T. et al. (2010). Modelling of drug disposition kinetics in in vitro intestinal absorption cell models. Basic and Clinical Pharmacology and Toxicology 106 (3): 180–188.

2 Becker, D.E. and Reed, K.L. (2012). Local anesthetics: review of pharmacological considerations. Anesthesia Progress 59 (2): 90–102.

3 Coleman, J.J. and Pontefract, S.K. (2016). Adverse drug reactions. Clinical Medicine 16 (5): 481–485.

4 Doogue, M.P. and Polasek, T.M. (2013). The ABCD of clinical pharmacokinetics. Therapeutic Advances in Drug Safety 4 (1): 5–7.

5 Fagerholm, U. (2007). Prediction of human pharmacokinetics – gastrointestinal absorption. Journal of Pharmacy and Pharmacology 59: 905–916.

6 Fujimoto, J.M. (1979). Pharmacokinetics and drug metabolism. In: Practical Drug Therapy, 1e (ed. R.I.H. Wang), 11–16. Philadelphia: J.B. Lippincott Company.

7 Gossel, T.A. (1998a). Pharmacology back to basics. US Pharmacist 23: 70–78.

8 Gossel, T.A. (1998b). Exploring pharmacology. US Pharmacist 23: 96–104.

9 Huang, W., Lee, S.L., and Yu, L.X. (2009). Mechanistic approaches to predicting oral drug absorption. AAPS Journal 11: 217–224.

10 Ito, S. (2011). Pharmacokinetics 101. Paediatrics and Child Health 16 (9): 535–536.

11 Leheny, S. (2017). ‘Adverse Event,’ Not the Same as ‘Side Effect.’ www.pharmacytimes.com/contributor/shelby‐leheny‐pharmd‐candidate‐2017/2017/02/adverse‐event‐not‐the‐same‐as‐side‐effect.

12 Lloyd, B.L., Greenblatt, D.J., Allen, M.D. et al. (1978). Pharmacokinetics and bioavailability of digoxin capsules, solutions and tablets after single and multiple dose. American Journal of Cardiology 2: 129–136.

13 Mayer, M.H., Dowsett, S.A., Brahmavar, K. et al. (2010). Reporting adverse drug events. US Pharmacist 35: HS‐15–HS‐19.

14 Pond, S.M. and Tozer, T.N. (1984). First‐pass elimination. Basic concepts and clinical consequences. Clinical Pharmacokinetics 9: 1–25.

15 Rieder, M. and Ferro, A. (2015). Adverse drug reactions. British Journal of Clinical Pharmacology 80 (4): 613–614.

16 Riedl, M.A. and Casillas, A.M. (2003). Adverse drug reactions: types and treatment options. American Family Physician 68: 1781–1790.

17 Robertson, D. (2017). First pass metabolism. Nurse Prescribing 15 (6): 303–305.

18 Shamna, M., Dilip, C., Ajmal, M. et al. (2014). A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceutical Journal 22 (4): 303–308.

19 Tamargo, J., Le Heuzey, J.Y., and Mabo, P. (2015). Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. European Journal of Clinical Pharmacology 71 (5): 549–567.

20 Thomson, A. (2004a). Back to basics: pharmacokinetics. Pharmaceutical Journal 272: 796–771.

21 Thomson, A. (2004b). Variability in drug dosage requirements. Pharmaceutical Journal 272: 806–808.

22 VA Center for Medication Safety and VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel (2006). Adverse drug events, adverse drug reactions and medication errors. Frequently asked questions. www.pbm.va.gov/PBM/vacenterformedicationsafety/tools/AdverseDrugReaction.pdf.

23 Weinberg, M.A. (2013). Fundamentals of drug action. In: Oral Pharmacology, 2e (eds. M.A. Weinberg, C. Westphal and J.B. Fine), 18–40. New Jersey: Pearson Education Inc.

24 Wesolowski, C.A., Wesolowski, M.J., Babyn, P.S., and Wanasundara, S.N. (2016). Time varying apparent volume of distribution and drug half‐lives following intravenous bolus injections. PLoS One 11 (7): e0158798. https://doi.org/10.1371/journal.pone.0158798.